Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Angioma Alliance DNA/Tissue Bank and Patient Registry Resource Report Resource Website |
Angioma Alliance DNA/Tissue Bank and Patient Registry (RRID:SCR_004390) | Angioma Alliance DNA/Tissue Bank and Patient Registry | biomaterial supply resource, material resource, tissue bank | Angioma Alliance has established a DNA/Tissue Bank and matching clinical database for cerebral cavernous malformations (CCM, cavernous angioma, cavernoma). Our goal is to create the world''s largest collection of CCM genetic samples with matching clinical data to be used as a resource to drive research. We are recruiting individuals with a history of cerebral cavernous malformations to participate in the study. Qualified participants donate a blood sample and complete a comprehensive questionnaire or interview. Blood donation kits will be sent in the mail for participants to take to their doctor, clinic or blood draw center to have their blood drawn. The kit is then mailed to a private lab where the sample is processed. If a surgery is scheduled, the Angioma Alliance DNA/Tissue Bank will work with the participant, the surgeon, and the hospital to coordinate tissue donation. If surgery scheduling allows, dry ice will be shipped to the hospital facility along with a tissue collection kit for use and return to the private lab. The Angioma Alliance DNA/Tissue Bank will attempt to acquire Institutional Review Board approvals at facilities where this is required. The Angioma Alliance BioBank will follow up with participants on a yearly basis to update their clinical information. If the participant has not already had documented genetic testing, we will test their DNA sample for possible CCM1, CCM2, or CCM3 mutation or CCM2 exon 2-10 deletion. If additional causative genes are identified for the illness, we will also test for mutations on these. Participants will not be informed of the results of testing, but if a mutation or deletion is found, they will be informed that results can be released to a diagnostic laboratory in order to obtain follow-up confirmatory clinical diagnostic testing. This could mean a substantial cost savings to the patient whose insurance does not cover genetic testing or who is uninsured. All researchers requesting the use of DNA and/or Tissue samples from Angioma Alliance must complete an application form and material transfer agreement. | cerebral cavernous malformation, cavernous angioma, cavernoma, clinical, blood, dna, fresh, frozen, ccm lesion tissue, ccm1, ccm2, frozen, paraffin section, slides, ccm3, paraffin-embedded, public |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Angioma Alliance |
Angioma, Cerebral cavernous malformation, Cavernous angioma, Cavernoma | Angioma Alliance | Public | nlx_143719 | SCR_004390 | Angioma Alliance BioBank, Cerebral Cavernous Malformations DNA and Tissue Bank, Cerebral Cavernous Malformations (CCM) DNA & Tissue Bank, CCM DNA & Tissue Bank, CCM DNA and Tissue Bank, Cerebral Cavernous Malformations (CCM) DNA and Tissue Bank | 2026-09-12 01:01:31 | 0 | |||||
|
MD Anderson Gynecologic Cancer Tissue Bank Resource Report Resource Website |
MD Anderson Gynecologic Cancer Tissue Bank (RRID:SCR_005004) | MD Anderson Gynecologic Cancer Tissue Bank | biomaterial supply resource, material resource, tissue bank | The purpose of the Multidisciplinary Gynecologic Cancer Translational Research Tissue Bank is to provide investigators with primary human tissue for research projects relating to gynecologic cancer. Priority for samples is given to the MD Anderson scientific community. This tissue bank handles the consent, collection, processing, storage and distribution of primary gynecologic tumor samples as well as ascites, blood and urine of gynecologic cancer patients. | clinical, tissue, tumor, ascites, blood, urine, peritoneal cavity fluid, gynecologic cancer, gynecologic tumor, cancer, tumor |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Texas MD Anderson Cancer Center |
Gynecologic cancer, Gynecologic tumor | Private/Public: Priority for samples is given to the MD Anderson scientific community. | nlx_96124 | http://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/multidisciplinary-gynecologic-cancer-translational-research-tissue-bank/index.html | SCR_005004 | MD Anderson Cancer Center Gynecologic Cancer Translational Research Tissue Bank, Multidisciplinary Gynecologic Cancer Translational Research Tissue Bank, MD Anderson Cancer Center Gynecologic Cancer Tissue Bank | 2026-09-12 01:01:35 | 0 | |||||
|
Erasmus MC Tissue Bank Resource Report Resource Website 1+ mentions |
Erasmus MC Tissue Bank (RRID:SCR_004945) | Erasmus MC Tissue Bank | biomaterial supply resource, material resource, tissue bank | The Erasmus MC Virtual Tissue Bank is embedded in the department of Pathology. The collection is meant for medical research purposes only. This concerns a typical clinical based pathology biobank. Tissue samples left over from surgical resection specimen are stored under liquid nitrogen and can be requested by Erasmus MC scientists for medical scientific experiments. An application has been developed to enable scientists to search the collection on-line and request tissue samples over the Erasmus MC Intranet. Every request shall be judged according to procedures determined by the Erasmus MC Tissue Bank. A growing need is anticipated for large collections of well-diagnosed fresh frozen tumor tissue and, if available, corresponding pre-malignant and normal tissue samples. Scientific research on patient residual material has to comply with strict rules and regulations. Equipment The Erasmus MC Tissue bank manages the PALM microdissection laser for the center for Biomics, which is available through the center for Biomics ONLY after having followed an introduction course. Additionally, a complete TMA (Tissue Micro Array) platform, fully funded by the Josephine Nefkens Stichting, consisting of a Beecher Automated Tissue Arrayer ATA 27 and a Virtual Microscope or Nanozoomer from Hamamatsu and Medical Solutions with TMA analyses software strongly supports translational research on tissue samples. Complete histologic Images from the Virtual Microscope are available within the Erasmus MC Intranet or available on the Internet either by overview or a direct example. | clinical, tumor tissue, tissue, pre-malignant tissue, normal tissue, liquid nitrogen, fresh frozen, frozen, tumor | is listed by: One Mind Biospecimen Bank Listing | Tumor | European Union | Private: Tissue samples left over from surgical resection specimen are stored under liquid nitrogen and can be requested by Erasmus MC scientists for medical scientific experiments. | nlx_91504 | http://www.erasmusmc.nl/pathologie/clinicalpathology/tissuebank/161390/ | SCR_004945 | Erasmus Medical Center Tissue Bank, Erasmus MC Virtual Tissue Bank | 2026-09-12 01:01:34 | 1 | ||||
|
MD Anderson Pancreas Tissue Bank Resource Report Resource Website |
MD Anderson Pancreas Tissue Bank (RRID:SCR_004983) | PTB | biomaterial supply resource, material resource, tissue bank | THIS RESOURCE IS NO LONGER IN SERVICE, documented September 2, 2016. A clinical database and PTB were created in 1990 and 2000, respectively, to collect clinical information and biospecimens from patients with suspected or confirmed pancreatic cancer, other pancreatic diseases, and tumors of the duodenum, ampulla of Vater, and distal bile duct. Standard procedures for biospecimen collection and data entry were developed. The use of human tissue for research is an invaluable tool to understand the basic mechanisms of tumor biology, which will hopefully lead to the development of new therapeutic approaches to pancreatic cancer treatment. The cornerstone of any large translational research program is the development of an accurate and comprehensive tumor bank. All tumors removed in the operating room are sampled for careful pathologic study and the remainder of the tumor is promptly stored in our Pancreas Tissue Bank (PTB) to be used for research. Other samples, including blood, pancreatic juice and biopsy material, can also be utilized to identify early markers for pancreatic cancer. The molecular profile of tumors in the PTB can be linked to information in our clinical database to provide insight on the relationship between molecular events and clinical outcome. Patients may contribute to the tissue banking effort by choosing to participate in select research protocols. Protecting patient privacy is of great importance and thus, to maintain the confidentiality of health information, the PTB complies with all federal and institutional regulations governing research with human participants. | clinical, tumor, cancer, bodily fluid, tissue, tumor, blood, pancreatic juice, biopsy material, pancreatic cancer, pancreatic disease, tumor of the duodenum, tumor of the ampulla of vater, tumor of the distal bile duct |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Texas MD Anderson Cancer Center |
Pancreatic cancer, Pancreatic disease, Tumor of the duodenum, Tumor of the ampulla of Vater, Tumor of the distal bile duct | PMID:18256882 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_94016 | http://www.mdanderson.org/education-and-research/research-at-md-anderson/basic-science/research-programs/pancreatic-cancer-research/from-bench-to-bedside/human-tumor-bank-database-expansion.html | SCR_004983 | MD Anderson PTB, MD Anderson Pancreatic Cancer Study Group Human Tumor Bank and Database | 2026-09-12 01:01:35 | 0 | ||||
|
Stanley Medical Research Institute Online Genomics Database Resource Report Resource Website 10+ mentions |
Stanley Medical Research Institute Online Genomics Database (RRID:SCR_004859) | Stanley Online Genomics Database | data or information resource, database | The Stanley Online Genomics Database uses samples from the Stanley Medical Research Institute (SMRI) Brain Bank. These samples were processed and run on gene expression arrays by a variety of researchers in collaboration with the SMRI. These researchers have performed analyses on their respective studies using a range of analytic approaches. All of the genomic data have been aggregated in this online database, and a consistent set of analyses have been applied to each study. Additionally, a comprehensive set of cross-study analyses have been performed. A thorough collection of gene expression summaries are provided, inclusive of patient demographics, disease subclasses, regulated biological pathways, and functional classifications. Raw data is also available to download. The database is derived from two sets of brain samples, the Stanley Array collection and the Stanley Consortium collection. The Stanley Array collection contains 105 patients, and the Stanley Consortium collection contains 60 patients. Multiple genomic studies have been conducted using these brain samples. From these studies, twelve were selected for inclusion in the database on the basis of number of patients studied, genomic platform used, and data quality. The Consortium collection studies have fewer patients but more diversity in brain regions and array platforms, while the Array collection studies are more homogenous. There are tradeoffs, the Consortium results will be more variable, but findings may be more broadly representative. The collections contain brain samples from subjects in four main groups: Bipolar Schizophrenia, Depression, and Controls Brain regions used in the studies include: Broadman Area 6, Broadman Area 8/9, Broadman Area 10, Broadman Area 46, Cerebellum The 12 studies encompass a range of microarray platforms: Affymetrix HG-U95Av2, Affymetrix HG-U133A, Affymetrix HG-U133 2.0+, Codelink Human 20K, Agilent Human I, Custom cDNA Publications based on any of the clinical or genomic data should credit the Stanley Medical Research Institute, as well as any individual SMRI collaborators whose data is being used. Publications which make use of analytic results/methods in the database should additionally cite Dr. Michael Elashoff. Registration is required to access the data. | clinical, genomic, gene expression, microarray, bipolar disorder, schizophrenia, depressive disorder, control, brain, brodmann area 6, brodmann area 8, brodmann area 9, brodmann (1909) area 10, brodmann area 46, cerebellum, FASEB list | has parent organization: Stanley Medical Research Institute | PMID:16594998 | nlx_143935 | SCR_004859 | SMRI Online Genomics Database | 2026-09-12 01:01:34 | 33 | |||||||
|
BioMarkers for SMA Data Portal Resource Report Resource Website 1+ mentions |
BioMarkers for SMA Data Portal (RRID:SCR_004920) | BforSMA | data or information resource, database | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 11, 2023. A publicly available tool that contains data from the BforSMA clinical study ( ClinicalTrials.gov, NCT00756821 ), a pilot study to identify candidate biomarkers in blood or urine from a wide range of Spinal Muscular Atrophy (SMA) patients that associate with disease severity. It is hoped that the identification of candidate biomarkers will lead to clinical efficacy and longitudinal natural history studies to verify these markers and enable their use as validated pharmacodynamic markers, longitudinal progression markers, or surrogate endpoint measures in clinical trials. | sma, biomarker, child, disease, genetic disease, clinical, proteomic, metabolomic, transcriptomic, blood, urine | has parent organization: Neuroscience Information Framework | Spinal Muscular Atrophy | SMA Foundation | PMID:23565191 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_88529 | http://neuinfo.org/bforsma http://transmart-dev.neuinfo.org/transmart/search | SCR_004920 | Biomarkers for Spinal Muscular Atrophy, BforSMA Data Portal, Biomarkers for SMA, Biomarkers for Spinal Muscular Atrophy Data Portal | 2026-09-12 01:01:34 | 2 | |||
|
Stroke Patient Recovery Research Database (SPReD) Resource Report Resource Website |
Stroke Patient Recovery Research Database (SPReD) (RRID:SCR_005508) | SPReD | data or information resource, database, image | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 28,2025. The Stroke Patient Recovery Research Database (SPReD) initiative creates the infrastructure needed for the collection of a wide range of data related to stroke risk factors and to stroke recovery. It also promotes the analysis and management of large brain and vessel images. A major goal is to create a comprehensive electronic database Stroke Patient Recovery Research Database or SPReD and populate it with patient data, including demographic, biomarker, genetic and proteomic data and imaging data. SPReD will enable us to combine descriptions of our stroke patients from multiple projects that are geographically distributed. We will do this in a uniform fashion in order to enhance our ability to document rates of recovery; to study the effects of vascular risk factors and inflammatory biomarkers; and to use these data to improve their physical and cognitive recovery through innovative intervention programs. This comprehensive database will provide an integrated repository of data with which our researchers will investigate and test original ideas, ultimately leading to knowledge that can be applied clinically to benefit stroke survivors. | stroke, demographic, biomarker, genetic, proteomic, imaging, clinical, brain, vessel, risk factor, recovery | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_144609 | SCR_005508 | Stroke Patient Recovery Research Database | 2026-09-12 01:01:38 | 0 | ||||||||
|
Center for Computational Biology at UCLA Resource Report Resource Website |
Center for Computational Biology at UCLA (RRID:SCR_000334) | CCB, UCLA CCB, USC CCB | data or information resource, organization portal, portal | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on August 31, 2022. Center focused on the development of computational biological atlases of different populations, subjects, modalities, and spatio-temporal scales with 3 types of resources: (1) Stand-alone computational software tools (image and volume processing, analysis, visualization, graphical workflow environments). (2) Infrastructure Resources (Databases, computational Grid, services). (3) Web-services (web-accessible resources for processing, validation and exploration of multimodal/multichannel data including clinical data, imaging data, genetics data and phenotypic data). The CCB develops novel mathematical, computational, and engineering approaches to map biological form and function in health and disease. CCB computational tools integrate neuroimaging, genetic, clinical, and other relevant data to enable the detailed exploration of distinct spatial and temporal biological characteristics. Generalizable mathematical approaches are developed and deployed using Grid computing to create practical biological atlases that describe spatiotemporal change in biological systems. The efforts of CCB make possible discovery-oriented science and the accumulation of new biological knowledge. The Center has been divided into cores organized as follows: - Core 1 is focused on mathematical and computational research. Core 2 is involved in the development of tools to be used by Core 3. Core 3 is composed of the driving biological projects; Mapping Genomic Function, Mapping Biological Structure, and Mapping Brain Phenotype. - Cores 4 - 7 provide the infrastructure for joint structure within the Center as well as the development of new approaches and procedures to augment the research and development of Cores 1-3. These cores are: (4)Infrastructure and Resources, (5) Education and Training, (6) Dissemination, and (7) Administration and Management. The main focus of the CCB is on the brain, and specifically on neuroimaging. This area has a long tradition of sophisticated mathematical and computational techniques. Nevertheless, new developments in related areas of mathematics and computational science have emerged in recent years, some from related application areas such as Computer Graphics, Computer Vision, and Image Processing, as well as from Computational Mathematics and the Computational Sciences. We are confident that many of these ideas can be applied beneficially to neuroimaging. | functional, genetic, biological system, brain, clinical, computational, computational mathematic, disease, health, image processing, physiological, population, structural, neuroimaging, computational neuroscience, imaging genomics, magnetic resonance, pet, spect |
is listed by: NeuroImaging Tools and Resources Collaboratory (NITRC) is related to: National Centers for Biomedical Computing has parent organization: Laboratory of Neuro Imaging |
NCRR U54 RR021813 | PMID:22081221 | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-10492 | http://ccb.loni.ucla.edu/ | http://www.nitrc.org/projects/ccb, http://cms.loni.ucla.edu/CCB/ | SCR_000334 | CCB at UCLA, Center for Computational Biology | 2026-09-12 01:00:51 | 0 | |||
|
Coalition For Accelerating Standards and Therapies Resource Report Resource Website 1+ mentions |
Coalition For Accelerating Standards and Therapies (RRID:SCR_000206) | CFAST | data or information resource, portal | Consortium establishing data standards, tools and methods for conducting research in therapeutic areas important to public health including Alzheimer's disease, Parkinson's disease, multiple sclerosis, polycystic kidney disease, and tuberculosis.CDISC and C-Path have agreed to discontinue using separate CFAST brand, but they both remain committed to this mission and continue to partner to develop and publish therapeutic area data standards. | CDISC, C-Path, drug, clinical trial, data element, data sharing, clinical, virology |
is listed by: Consortia-pedia has parent organization: Critical Path Institute; Arizona; USA |
FDA 1U01FD003865-01 | nlx_157879 | SCR_000206 | Coalition For Accelerating Standards and Therapies (CFAST) | 2026-09-12 01:00:51 | 1 | |||||||
|
BioEden Tooth Cell Bank Resource Report Resource Website 1+ mentions |
BioEden Tooth Cell Bank (RRID:SCR_000507) | BioEDEN | biomaterial supply resource, cell repository, material resource | International private stem cell storage bank to collect, assess and cryogenically store living tooth cells from deciduous baby teeth. Tooth cell banking is a safe, natural and completely noninvasive method of collecting and preserving valuable stem cells which could hold the key to your child's health. Simply enroll, send us your child's tooth when it falls out, and they'll do the rest. Stem cell treatment to repair or replace damaged tissues or organs is the cornerstone of future medical science. Children's milk teeth, (baby teeth) have been identified as a rich source of these stem cells and have the potential to treat some of the worst illnesses and diseases facing people today. Stem cells from teeth (mesenchymal stem cells) are different from those found in cord blood (hematopoietic stem cells). Cord blood cells can be used to treat blood disorders such as leukemia, but stem cells from teeth are different. Stem cells from teeth can be used to grow a range of tissues including bone, nerve, fat, muscle and cartilage and may one day be used to grow entire organs. It is widely believed that stem cells will be used to treat a wide variety of diseases and injuries within the next decade. Their UK facility is regulated by the Human Tissue Authority (HTA), and they hold a full license. They are also registered with the Food and Drug Administration (FDA) in the US. BioEDEN, Ltd is ISO 9001:2008 accredited by the British Assessment Bureau. When you enroll for the BioEDEN service, you will be offered the opportunity to consent to donate any excess cells. BioEDEN will provide these cells to leading academic and clinical research centers to help further the progression of this technology to useful clinical applications. BioEDEN will only provide cells to researchers that have full ethical approval for their research and will be guided by our Advisory team as to the most appropriate research to support. The cells will be donated in accordance with strict regulatory guidelines and anonymity of the donor will be strictly assured at all times. Donation of cells is an entirely opt in service. If you choose not to give consent to donate, BioEDEN will simply store the cells for your child. | clinical, cryopreserved, frozen, stem cell, cell, tooth, mesenchymal stem cell, transplantation, research | is listed by: One Mind Biospecimen Bank Listing | Loss of tooth | Public | nlx_25195 | SCR_000507 | 2026-09-12 01:00:51 | 2 | |||||||
|
EpiTarget Resource Report Resource Website 1+ mentions |
EpiTarget (RRID:SCR_003771) | EPITARGET | data or information resource, portal | A multidisciplinary project focused on the process leading to epilepsy, epileptogenesis, in adults. Their main hypothesis is that there are combinations of various causes, acting in parallel and/or in succession, that lead to epileptogenesis and development of seizures. Their central premise and vision is that a combinatorial approach is necessary to identify appropriate biomarkers and develop effective antiepileptogenic therapeutics. The project will focus on: * identifying novel biomarkers and their combinations for epileptogenesis after potentially epileptogenic brain insults in clinically relevant animal models, such as traumatic brain injury (TBI) and status epilepticus (SE); * exploring multiple basic mechanisms of epileptogenesis and their mutual interactions; * and translating these findings towards the clinic by validating biomarkers in human samples accessible to the consortium. | common data element, preclinical, target, biomarker, antiepileptogenesis, adult human, animal model, clinical | has parent organization: Lund University; Lund; Sweden | Epilepsy | European Union FP7 602102 | nlx_158041 | SCR_003771 | EPITARGET - Targets and biomarkers for antiepileptogenesis | 2026-09-12 01:00:54 | 7 | ||||||
|
Bellvitge Biomedical Research Institute Resource Report Resource Website 10+ mentions |
Bellvitge Biomedical Research Institute (RRID:SCR_003917) | IDIBELL | data or information resource, organization portal, portal | A research center focused on cellular medicine, where the basic research focuses and works on relevant clinical matters and fosters economic development. The center manages the research of the Bellvitge University Hospital, the Institut Catal�� d''Oncologia (Catalan Institute of Oncology) and the University of Barcelona. It is one of the first five Spanish research centers accredited as health research institute by the Instituto de Salud Carlos III (Health Institute Carlos III). | cellular medicine, cell, medicine, clinical |
is related to: PRECISESADS has parent organization: University of Barcelona; Barcelona; Spain |
nlx_158270 | SCR_003917 | Institut d''Investigaci�� Biom��dica de Bellvitge (IDIBELL), Institut d''Investigacio Biomedica de Bellvitge (IDIBELL), Fundaci�� Institut d''Investigaci�� Biom��dica de Bellvitge, Institut d''Investigaci�� Biom��dica de Bellvitge, Institut d''Investigacio Biomedica de Bellvitge | 2026-09-12 01:00:54 | 28 | ||||||||
|
European Multicenter Study about Spinal Cord Injury Resource Report Resource Website 10+ mentions |
European Multicenter Study about Spinal Cord Injury (RRID:SCR_003720) | EMSCI | data or information resource, database, organization portal, portal | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 6, 2023. A clinical spinal cord injury network that provides a database of clinical assessment data from spinal cord injured patients. The EMSCI assessment scheme currently consists of the so called core sets: neurological (ISNCSCI), functional (10MWT, 6MWT, TUG, WISCI2) measurements and independence measures (SCIM3). Additional assessments are: neurophysiology (MEP, SSEP, NCV), pain, hand function and an urodynamics. | clinical assessment, spinal cord, injury, network, neurological, functional, independence, neurophysiology, pain, hand function, urodynamics, therapeutic intervention, clinical | Spinal cord injury, Paraplegic | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_157896 | SCR_003720 | 2026-09-12 01:00:54 | 37 | ||||||||
|
Turkish Human Mutation Database Resource Report Resource Website |
Turkish Human Mutation Database (RRID:SCR_008246) | data or information resource, database | The Molecular Biology and Genetics Department at Bogazii University is one of the major reference laboratories in Turkey, specialized in molecular analysis of common genetic disorders. Over the years, the rapid accumulation of mutation data in connection with detailed clinical and laboratory information, has led to the idea of establishing a national database for storing, analysing and presenting it in a more efficient and systematic way. For this purpose, an interdisciplinary project was initiated in 1995. b-Thalassemia and Hemophilia-B Databases were selected as preliminary models, for they offer alternative design and implementation strategies due to different clinical and genetic characteristics. b-Thalassemia is an autosomal recessive disorder, characterized by microcytosis and hemolytic anemia, which is the result of reduced b-Globin chain synthesis. In Turkey, the disease is represented with a gene frequency of 2 and reflected by a wide spectrum of clinical manifestations with the presence of more than 40 different mutation. Currently, there is no database available for thalassemia mutations. Hemophilia B is an X-linked recessive disorder caused by heterogenous mutations, resulting in a marked deficit of coagulation factor IX (FIX); an essential component of the clotting mechanism. A hemophilia B database was first published in 1990 as a list of point mutations and short additions and deletions with 115 mutations comprising 216 entries Gene-, System-, or Disease- Specific Databases | gene-, genetic, anemia, autosomal, b-globin, biology, b-thalassemia, clinical, clotting, coagulation, disorder, hemolytic, hemophilia-b, heterogenous, laboratory, mechanism, microcytosis, model, molecular, mutation, or disease- specific databases, synthesis, system- | nif-0000-21404 | http://www.medinfo.hacettepe.edu.tr/hmuttr/ | SCR_008246 | Human Mutation Database | 2026-09-12 01:01:59 | 0 | |||||||||
|
Integrated Tumor Transcriptome Array and Clinical data Analysis Resource Report Resource Website 1+ mentions |
Integrated Tumor Transcriptome Array and Clinical data Analysis (RRID:SCR_008182) | ITTACA | data or information resource, database | THIS RESOURCE IS NO LONGER IN SERVICE, documented on 6/12/25. ITTACA is a database created for Integrated Tumor Transcriptome Array and Clinical data Analysis. ITTACA centralizes public datasets containing both gene expression and clinical data and currently focuses on the types of cancer that are of particular interest to the Institut Curie: breast carcinoma, bladder carcinoma, and uveal melanoma. ITTACA is developed by the Institut Curie Bioinformatics group and the Molecular Oncology group of UMR144 CNRS/Institut Curie. A web interface allows users to carry out different class comparison analyses, including comparison of expression distribution profiles, tests for differential expression, patient survival analyses, and users can define their own patient groups according to clinical data or gene expression levels. The different functionalities implemented in ITTACA are: - To test if one or more gene, of your choice, is differentially expressed between two groups of samples exhibiting distinct phenotypes (Student and Wilcoxon tests). - The detection of genes differentially expressed (Significance Analysis of Microarrays) between two groups of samples. - The creation of histograms which represent the expression level according to a clinical parameter for each sample. - The computation of Kaplan Meier survival curves for each group. ITTACA has been developed to be a useful tool for comparing personal results to the existing results in the field of transcriptome studies with microarrays. | expression, gene, analysis, array, bioinformatics, bladder, breast, cancer, carcinoma, clinical, integrated, melanoma, microarray, molecular, oncology, patient, phenotype, survival, transcriptome, tumor, uveal | has parent organization: Curie Institute; Paris; France | PMID:16381943 | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-21227 | SCR_008182 | ITTACA | 2026-09-12 01:01:58 | 4 | ||||||
|
International Database of Tetrahydrobiopterin Deficiencies Resource Report Resource Website |
International Database of Tetrahydrobiopterin Deficiencies (RRID:SCR_008171) | data or information resource, database | THIS RESOURCE IS NO LONGER IN SERVICE, documented on August 26, 2016. The BIODEF database have tabulated the most common clinical and laboratory data related to hyperphenylalaninaemia and tetrahydrobiopterin deficiencies. Additionally, there are data regarding treatment, outcome, and DNA analysis. Approximately 2% of newborns with hyperphenylalaninaemia are deficient in tetrahydrobiopterin. Selective screening must be performed in all instances where hyperphenylalaninaemia is detected by neonatal screening. In the last 20 years, 308 patients with tetrahydrobiopterin deficiencies have been recognized as a result of screening carried out, worldwide, in Departments of Paediatrics. Of these 308 patients, 181 suffered from 6-pyruvoyltetrahydropterin synthase deficiency, 92 from dihydropteridine reductase deficiency, 13 from pterin-4a-carbinolamine dehydratase deficiency, 12 from GTP cyclohydrolase I deficiency, and 10 are still unclassified. The BIODEF database have tabulated the most common clinical and laboratory data related to hyperphenylalaninaemia and tetrahydrobiopterin deficiencies. Additionally, there are data regarding treatment, outcome, and DNA analysis. Preliminary evaluation reveals that the degree of hyperphenylalaninaemia can vary from normal to 2500 mumol/L. Analyses of pterins in urine and measurement of dihydropteridine reductase activity from Guthrie cards are absolutely essential tests for accurate diagnosis. There is a regional (demographic) variation in the frequency of tetrahydrobiopterin deficiencies indicating the highest incidence in Saudi Arabia, probably a consequence of the high consanguinity rate. | ethnic, frequency, 6-pyruvoyltetrahydropterin synthase deficiency, analysis, bh4, clinical, deficiency, demographic, diagnosis, dihydropteridine reductase deficiency, dna, gtp cyclohydrolase i deficiency, hyperphenylalaninaemia, measurement, neonatal, origin, outcome, pterin, pterin-4a-carbinolamine dehydratase deficiency, sex, tetrahydrobiopterin, treatment, urine | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-21052 | SCR_008171 | BIODEF | 2026-09-12 01:01:58 | 0 | |||||||||
|
University of Kentucky's Alzheimer's Disease Center Resource Report Resource Website 1+ mentions |
University of Kentucky's Alzheimer's Disease Center (RRID:SCR_008766) | UK-ADC, UK ADC | biomaterial supply resource, material resource, tissue bank | An organization which includes a tissue bank, a database, study design consultation, clinical resources, and a community registry database. The UK-ADC shares data with the NIA national database (NACC), as well as with independent, qualified investigators both within and outside the UK-ADC. This resource's associated tissue bank is comprised of anonymized brain tissue, blood, and cerebrospinal fluid samples from patients in the clinic, as well as frozen post-mortem brain tissue samples. This organization also shares research resources with the National Alzheimer's Coordinating Center (NACC), NACC collaborative initiatives, the Alzheimer's Disease Neuroimaging Initiative (ADNI), other Alzheimer Disease Centers (ADCs), and any qualified investigators from either the University of Kentucky or the general scientific community. | post-mortem, brain, brain tissue, cerebral spinal fluid, serum, plasma, buffy coat, blood, alzheimer's disease, dementing disorder, mild cognitive impairment, dementia, frozen, formalin fixed, paraffin embedded slide, clinical, neuropathology, neuropathologic disease, neuropathologic diagnosis, clinical, registry |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Kentucky Alzheimer's Disease Center |
Alzheimer's disease, Dementing disorder, Dementia, Neuropathologic diagnosis | NIA P30 AG028383 | Public | nlx_144056 | http://www.mc.uky.edu/coa/clinicalcore/alzheimercenter.html#neuropathology, http://www.mc.uky.edu/coa/clinicalcore/Neuropathology%20Core.html | SCR_008766 | University of Kentucky Alzheimer's Disease Center Biospecimen Data or Clinical Request, UK-Alzheimer's Disease Center Biospecimen Data or Clinical Request | 2026-09-12 01:02:01 | 1 | ||||
|
Task Independent Fluctuations Discussion Resource Report Resource Website |
Task Independent Fluctuations Discussion (RRID:SCR_009515) | Task Independent Fluctuations Discussion | data or information resource, discussion, narrative resource, software resource | The methodology and applications of task independent fluctuation measures including: connectivity maps of fMRI resting state scans, research using EEG/MEG/PET etc, methods to remove non-neural fluctuations, and applications to clinical populations. | community, information resource, knowledge environment, model, magnetic resonance, other software resource, web environment, fmri, fmri resting state, eeg, meg, pet, non-neural fluctuation, clinical | is listed by: NeuroImaging Tools and Resources Collaboratory (NITRC) | nlx_155677 | SCR_009515 | 2026-09-12 01:02:02 | 0 | |||||||||
|
Gazel Database Resource Report Resource Website 1+ mentions |
Gazel Database (RRID:SCR_008962) | Gazel | data or information resource, database | A 20 year, 20,000 person, open longitudinal epidemiological study of a cohort town. GAZEL was not constructed to answer a specific question rather it was designed to help analyze a wide range of scientific problems and is accessible to the community of researchers specializing in epidemiology. Translation is not available for all pages. The GAZEL cohort, set up in 1989 by Inserm Unit 88 (subsequently Unit 687), in cooperation with several departments of ��lectricit�� de France-Gaz de France (EDF-GDF), was a public utility firm in France involved in production, transmission and distribution of energy. GAZEL initially included 20 624 volunteers working at EDF-GDF (15 010 men and 5614 women), aged from 35 to 50 years. In accordance with its purpose as a scientific research platform, the GAZEL cohort is permanently open to epidemiologic research teams. Today, more than 50 projects on very diversified themes have been set up in GAZEL by some 20 teams, French, belonging to different bodies, and foreign (Germany, Belgium, Canada, Great Britain, Sweden, Finland, and USA). | clinical, epidemiology, longitudinal, adult human, middle adult human, early adult human | has parent organization: National Institute of Health and Medical Research; Rennes; France | Aging | Restricted | r3d100011829, nlx_151989 | https://doi.org/10.17616/R3DH0P | SCR_008962 | 2026-09-12 01:02:02 | 3 | ||||||
|
Brain and Body Genetic Resource Exchange Resource Report Resource Website 1+ mentions |
Brain and Body Genetic Resource Exchange (RRID:SCR_008959) | BB-GRE | data or information resource, database | A database and associated tools for investigating the genetic basis of neurodisability. It combines phenotype information from patients with neurodevelopmental and behavioral problems with clinical genetic data, and displays this information on the human genome map. Basic access to genetic information (deletions, duplications) relating to participants with neurodevelopmental disorders is provided without an account; access to the full dataset requires an account. The genetic information that is available to view comprises potentially pathogenic copy number variation across the genome, detected by array comparative genome hybridization (aCGH) using a customized 44K oligonucleotide array. | developmental disorder, copy number, neurodevelopmental disorder, child, phenotype, genotype-phenotype, brain, genetic, gene, genotype, behavior, clinical, genome, neurodevelopment, behavioral disorder, genetic variant, development | has parent organization: King's College London; London; United Kingdom | Schizophrenia, Mental retardation, Attention deficit hyperactivity disorder, Developmental language delay, Dyslexia, Sleep disorder, Epilepsy, Dysmorphism, Neurodisability, Autism | Acknowledgement required | nlx_151987 | http://bbgre-dev.iop.kcl.ac.uk/info/about-us | SCR_008959 | BBGRE.org, Brain & Body Genetic Resource Exchange, BB-GRE database | 2026-09-12 01:02:02 | 1 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
